Lancet comments on PBRT in treatment of prostate cancer

On June 5 we had noted that, the day before, the American Society for Radiation Oncology (ASTRO) released its model policy on the use of proton beam radiation therapy (PBRT) and related reimbursement issues. … READ MORE …

Reimbursement for PBRT in the treatment of prostate cancer

According to a “model policy” statement just issued by the American Society for Radiation Oncology (ASTRO), reimbursement for costs related to the treatment of prostate cancer with proton beam radiation therapy (PBRT) should come with some very specific requirements. … READ MORE …

Prostate Cancer Roundtable updates national policy agenda

The Prostate Cancer Roundtable has just announced an update to its national policy agenda — to include a focus on the importance of patient-reported outcomes data affecting quality of life in trials designed with survival as the primary endpoint. … READ MORE …

Prostate Cancer Roundtable updates policy agenda for 2013

The Prostate Cancer Roundtable has announced an update to its policy agenda for 2013, concurrent with the start of the work of the new Congress here in the USA. … READ MORE …

Disagreement over prostate cancer screening guidelines in Oz

Here in the USA, the two main organizations representing the primary care community ( the American College of Physicians [ACP] and the American Academy of Family Physicians [AAFP]) have taken no specific position on early detection and screening for prostate cancer since the ACP issued a now “inactive” guideline in 1997. … READ MORE …

Prostate Cancer Roundtable gets web site up and running

It has taken a while to get there but the Prostate Cancer Roundtable finally has its own web site up and running. This will make it a good deal easier for people to keep up to date with the shared advocacy agenda and related activities of the major, US-based, patient-centric prostate cancer organizations. … READ MORE …

French government implements special reimbursement policy for HIFU

According to a media release this morning the French national health authority (HAS) has put in place a special temporary reimbursement policy that will cover the use of high intensity focused ultrasound (HIFU) only for selected uses of this technique in the management of prostate cancer. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,156 other followers